Literature DB >> 20847881

Sentinel Node Biopsy in Breast Cancer: Clinical Implication - Standard of Care - Fututre Prospects.

Anton Haid1, Thorsten Kühn, Amit Goyal, Christoph Tausch, Florentina Peintinger, Peter Schrenk, Hans Gallowitsch.   

Abstract

Entities:  

Year:  2009        PMID： 20847881      PMCID： PMC2931009          DOI： 10.1159/000218329

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  17 in total

1.  Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer.

Authors:  M Ohta; Y Tokuda; Y Saitoh; Y Suzuki; A Okumura; M Kubota; H Makuuchi; T Tajima; S Yasuda; A Shohtsu
Journal:  Breast Cancer       Date:  2000-01       Impact factor: 4.239

2.  Implementation of sentinel lymph node biopsy with blue dye outside a specialized center: can we improve quality assurance?

Authors:  Florentia Peintinger; Roland Reitsamer; George Ralph
Journal:  Breast J       Date:  2005 Mar-Apr       Impact factor: 2.431

3.  Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study.

Authors:  Igor Langer; Ulrich Guller; Gilles Berclaz; Ossi R Koechli; Holger Moch; Gabriel Schaer; Mathias K Fehr; Thomas Hess; Daniel Oertli; Lucio Bronz; Beate Schnarwyler; Edward Wight; Urs Uehlinger; Eduard Infanger; Daniel Burger; Markus Zuber
Journal:  Breast Cancer Res Treat       Date:  2008-02-23       Impact factor: 4.872

4.  Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.

Authors:  Mattia Intra; Nicole Rotmensz; Paolo Veronesi; Marco Colleoni; Simona Iodice; Giovanni Paganelli; Giuseppe Viale; Umberto Veronesi
Journal:  Ann Surg       Date:  2008-02       Impact factor: 12.969

5.  Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases.

Authors:  Umberto Veronesi; Viviana Galimberti; Giovanni Paganelli; Patrick Maisonneuve; Giuseppe Viale; Roberto Orecchia; Alberto Luini; Mattia Intra; Paolo Veronesi; Pietro Caldarella; Giuseppe Renne; Nicole Rotmensz; Claudia Sangalli; Luciana De Brito Lima; Marco Tullii; Stefano Zurrida
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

6.  Breast sentinel lymph node dissection before preoperative chemotherapy.

Authors:  Baiba J Grube; Carla J Christy; Dalliah Black; Maritza Martel; Lyndsay Harris; Joanne Weidhaas; Michael P Digiovanna; Gina Chung; Maysa Mahmoud Abu-Khalaf; Kenneth D Miller; Susan A Higgins; Liane Philpotts; Fattaneh A Tavassoli; Donald R Lannin
Journal:  Arch Surg       Date:  2008-07

7.  Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information?

Authors:  H-J Gallowitsch; P Kraschl; I Igerc; T Hussein; E Kresnik; P Mikosch; S Kohlfuerst; K Hausegger; P Lind
Journal:  Nuklearmedizin       Date:  2007       Impact factor: 1.379

8.  A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.

Authors:  Savitri Krishnamurthy; Funda Meric-Bernstam; Anthony Lucci; Rosa F Hwang; Henry M Kuerer; Gildy Babiera; Fredrick C Ames; Barry W Feig; Merrick I Ross; Eva Singletary; Kelly K Hunt; Isabelle Bedrosian
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

9.  Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.

Authors:  Mike Visser; Mehdi Jiwa; Anja Horstman; Antoinette A T P Brink; Rene P Pol; Paul van Diest; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

10.  200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up.

Authors:  R Reitsamer; F Peintinger; E Prokop; L Rettenbacher; C Menzel
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.